InvestorsHub Logo
Followers 1321
Posts 246230
Boards Moderated 56
Alias Born 12/07/2009

Re: StockHighAlert- post# 264

Thursday, 07/16/2020 8:20:30 AM

Thursday, July 16, 2020 8:20:30 AM

Post# of 3535
“This study indicates that CUREform technology improved cannabinoid bioavailability, potentially allowing for a lower dose, which may facilitate a reduction in side effects and better compliance,” said Vered Gigi, PhD, Chief Scientific Officer of CURE Pharmaceutical. “We believe that our technology could be effectively applied to other molecules that have bioavailability challenges achieving multiple patient benefits.” $CURR


ALL comments are In My Own OPINION. Please Use Your Own DD for Stock Trading.